FIG
Freed Investment Group Portfolio holdings
AUM
$131M
This Quarter Return
+13.35%
1 Year Return
+30.33%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$109M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
98.07%
Holding
16
New
16
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Fidelity Nasdaq Composite Index ETF
ONEQ
|
$40.6M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$31.9M |
| 3 |
Apple
AAPL
|
$7.33M |
| 4 |
Amazon
AMZN
|
$7.1M |
| 5 |
Visa
V
|
$5.2M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 11.75% |
| 2 | Consumer Discretionary | 6.52% |
| 3 | Communication Services | 6.37% |
| 4 | Financials | 4.77% |
| 5 | Healthcare | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Fidelity Nasdaq Composite Index ETF
ONEQ
$8.5B
| $40.6M | 37.24% |
+808,480
| New | +$40.6M |
|
|
2
iShares Core S&P 500 ETF
IVV
$660B
| $31.9M | 29.31% |
+85,053
| New | +$31.9M |
|
|
3
Apple
AAPL
$3.54T
| $7.33M | 6.73% |
+55,251
| New | +$7.33M |
|
|
4
Amazon
AMZN
$2.41T
| $7.1M | 6.52% |
+43,600
| New | +$7.1M |
|
|
5
Visa
V
$681B
| $5.2M | 4.77% |
+23,772
| New | +$5.2M |
|
6
Microsoft
MSFT
$3.76T
| $5.07M | 4.66% |
+22,804
| New | +$5.07M |
|
7
Alphabet (Google) Class A
GOOGL
$2.79T
| $3.48M | 3.19% |
+39,680
| New | +$3.48M |
|
|
8
Alphabet (Google) Class C
GOOG
$2.79T
| $3.14M | 2.88% |
+35,800
| New | +$3.14M |
|
9
SPDR Dow Jones Industrial Average ETF Trust
DIA
$39.7B
| $2.35M | 2.16% |
+7,684
| New | +$2.35M |
|
|
CDAK
10
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $657K | 0.6% |
+20,328
| New | +$657K |
|
11
Johnson & Johnson
JNJ
$429B
| $574K | 0.53% |
+3,646
| New | +$574K |
|
12
VanEck Gold Miners ETF
GDX
$19.6B
| $562K | 0.52% |
+15,600
| New | +$562K |
|
13
NVIDIA
NVDA
$4.15T
| $391K | 0.36% |
+29,960
| New | +$391K |
|
14
Meta Platforms (Facebook)
META
$1.85T
| $322K | 0.3% |
+1,179
| New | +$322K |
|
15
SPDR S&P 500 ETF Trust
SPY
$656B
| $228K | 0.21% |
+610
| New | +$228K |
|
16
Citius Pharmaceuticals
CTXR
$20.8M
| $29K | 0.03% |
+1,140
| New | +$29K |
|